Biocartis Group Return On Asset vs. Price To Sales
| BCART Stock | EUR 0.29 0.00 0.00% |
For Biocartis Group profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biocartis Group to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biocartis Group NV utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biocartis Group's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biocartis Group NV over time as well as its relative position and ranking within its peers.
Biocartis |
Biocartis Group NV Price To Sales vs. Return On Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Biocartis Group's current stock value. Our valuation model uses many indicators to compare Biocartis Group value to that of its competitors to determine the firm's financial worth. Biocartis Group NV is rated second in return on asset category among its peers. It is rated third in price to sales category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Biocartis Group by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Biocartis Group's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Biocartis Price To Sales vs. Return On Asset
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Biocartis Group |
| = | -0.22 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Biocartis Group |
| = | 0.89 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Biocartis Price To Sales Comparison
Biocartis Group is currently under evaluation in price to sales category among its peers.
Biocartis Group Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Biocartis Group, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biocartis Group will eventually generate negative long term returns. The profitability progress is the general direction of Biocartis Group's change in net profit over the period of time. It can combine multiple indicators of Biocartis Group, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. The company was founded in 2007 and is headquartered in Mechelen, Belgium. BIOCARTIS operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange. It employs 619 people.
Biocartis Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Biocartis Group. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biocartis Group position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biocartis Group's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Biocartis Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Use Investing Themes to Complement your Biocartis Group position
In addition to having Biocartis Group in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Services Thematic Idea Now
Services
Companies involved in delivering services to business or consumers across different industries and sectors. The Services theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Services Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Biocartis Stock
To fully project Biocartis Group's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biocartis Group NV at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biocartis Group's income statement, its balance sheet, and the statement of cash flows.